Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ABT-384

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
  • G. An
  • Journal of clinical pharmacology
  • 2019
  • Corpus ID: 208609332
Target‐mediated drug disposition (TMDD) is a term to describe a nonlinear pharmacokinetic (PK) phenomenon that is caused by high… Expand
Is this relevant?
Review
2017
Review
2017
  • G. An
  • Journal of clinical pharmacology
  • 2017
  • Corpus ID: 29569379
Nonlinearities are commonplace in pharmacokinetics, and 1 special source is the saturable binding of the drug to a high‐affinity… Expand
Is this relevant?
2016
2016
Resume La 11β-hydroxysteroide deshydrogenase de type 1 (11βHSD1) est une enzyme intervenant dans la transformation tissulaire de… Expand
Is this relevant?
Review
2015
Review
2015
Nonlinearities are frequently encountered in pharmacokinetics, and they can occur when 1 or more processes of absorption… Expand
Is this relevant?
2014
2014
In this study we assessed increased cortisol in Alzheimer's disease (AD) patients. The selective 11‐β‐hydroxysteroid… Expand
Is this relevant?
2014
2014
ABT‐384 is a potent and selective inhibitor of 11β‐hydroxysteroid dehydrogenase type 1 (HSD‐1). The pharmacokinetics of ABT‐384… Expand
Is this relevant?
2013
2013
ABT‐384 is a potent and selective inhibitor of 11β‐hydroxysteroid dehydrogenase type 1 (HSD‐1), the enzyme that regenerates… Expand
Is this relevant?
2013
2013
ABT-384 is a potent, selective inhibitor of 11-beta-hydroxysteroid dehydrogenase type 1 (HSD-1). One milligram of ABT-384 daily… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
ABT-384 [1-piperazineacetamide, N-[5-(aminocarbonyl) tricyclo[3.3.1.13,7]dec-2-yl]-α,α-dimethyl-4-[5-(trifluoromethyl)-2… Expand
  • figure 2
  • figure 3
  • table 1
  • figure 4
  • table 2
Is this relevant?